Walleye Trading
LAB icon

Walleye Trading’s Standard BioTools LAB Stock Holding History

Walleye Trading’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300
Closed -$1K – 5417
2022
Q1 		$1K Sell
300
-53,400
-99% -$184K ﹤0.01% 5227
2021
Q4 		$211K Buy
53,700
+33,200
+162% +$155K ﹤0.01% 3814
2021
Q3 		$135K Buy
+20,500
New +$135K ﹤0.01% 4190
2020
Q2 		– Sell
-600
Closed -$2K – 4435
2020
Q1 		$2K Buy
+600
New +$1.97K ﹤0.01% 3839
2019
Q4 		– Sell
-22,800
Closed -$106K – 4434
2019
Q3 		$106K Buy
+22,800
New +$180K ﹤0.01% 3312
2016
Q2 		– Sell
-400
Closed -$4K – 5539
2016
Q1 		$4K Sell
400
-8,500
-96% -$61.3K ﹤0.01% 4996
2015
Q4 		$96K Buy
8,900
+8,800
+8,800% +$86.4K ﹤0.01% 3346
2015
Q3 		$1K Sell
100
-500
-83% -$7.87K ﹤0.01% 4831
2015
Q2 		$14K Buy
600
+100
+20% +$3.16K ﹤0.01% 4166
2015
Q1 		$21K Sell
500
-1,500
-75% -$59.3K ﹤0.01% 3493
2014
Q4 		$67K Buy
2,000
+500
+33% +$14.2K ﹤0.01% 3067
2014
Q3 		$36K Buy
+1,500
New +$42.2K ﹤0.01% 3309

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading's LAB Position: Q2 2022 in Review

Walleye Trading sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 13,125 shares — an estimated $47K sold.

Walleye Trading first reported a position in LAB in Q3 2014 and held it in 17 quarters. The position peaked at $385K in Q1 2019. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Walleye Trading reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 13,125 Standard BioTools shares in Q2 2022, an estimated $47K.
  • Walleye Trading first reported a position in Standard BioTools in Q3 2014 and held it in 17 quarters.
  • Walleye Trading's Standard BioTools position peaked at $385K in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.